Trial Profile
Optimal Combination Therapy After Nevirapine Exposure
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Nevirapine (Primary) ; Emtricitabine; Emtricitabine/tenofovir disoproxil fumarate; Lopinavir/ritonavir; Tenofovir disoproxil fumarate
- Indications HIV infections; HIV-1 infections
- Focus Therapeutic Use
- Acronyms OCTANE; OCTANE-1
- 07 Mar 2018 Results assessing association between virological failure of ART and HIV variant with dual-class resistance by using data from this study presented at the 25th Conference on Retroviruses and Opportunistic Infections.
- 26 Jul 2017 Results (n=253) of secondary analysis to understand the impact ART drugs on pregnancy and birth outcomes among women from this trial and HPTN 052 and ACTG A5175 trial, were presented at the 9th International AIDS Society Conference on HIV Science
- 08 Mar 2012 Extension study results presented at the 19th Conference on Retroviruses and Opportunistic Infections.